Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(63%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
4
50%
Ph phase_1
4
50%

Phase Distribution

4

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
4(50.0%)
Phase 3Large-scale testing
4(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(3)

Detailed Status

Active, not recruiting4
Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (50.0%)
Phase 34 (50.0%)

Trials by Status

recruiting113%
completed338%
active_not_recruiting450%

Recent Activity

5 active trials
Showing 5 of 8
active_not_recruitingphase_3

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT06767735
active_not_recruitingphase_1

Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment

NCT07193147
active_not_recruitingphase_3

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin

NCT06767761
recruitingphase_3

A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT07165223
active_not_recruitingphase_3

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT06767748
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06767735Phase 3

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)

Active Not Recruiting
NCT07193147Phase 1

Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment

Active Not Recruiting
NCT06767761Phase 3

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin

Active Not Recruiting
NCT07165223Phase 3

A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Recruiting
NCT06767748Phase 3

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Active Not Recruiting
NCT06547502Phase 1

Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment

Completed
NCT06553248Phase 1

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes

Completed
NCT06548815Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8